Archives

by in
Entry Author Date Location
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
DVS Sciences Secures $14,600,000 Series A Funding Round 07/14/11 San Francisco
Ambit Raises $30M Venture Round, After Pulling Plug on IPO 06/10/11 San Diego
Ambit Biosciences Receives $30,000,000 Series D Funding Round 06/10/11 San Diego
Ambit Withdraws IPO 06/08/11 San Diego
Conatus Raises $20M for Hepatitis C Studies 02/14/11 San Diego
Conatus Pharmaceuticals Receives $20,000,000 Series B Funding Round 02/13/11 San Diego
23andMe Adds $9M to VC Round 01/07/11 San Francisco
Ambit Bio Raises $15M 10/19/10 San Diego
Cytomx Pockets $30M, AvidBiotics Eyes Food Safety Market, Rigel Passes Arthritis Trial, & More Bay Area Life Sciences News 09/24/10 San Francisco
Cytomx, Backed by Third Rock & Roche, Raises $30M for New Class of Antibodies 09/23/10 San Francisco
CytomX Therapeutics Lands $30,000,000 New Financing 09/23/10 San Diego
Nereus Pharmaceuticals Receives $20,000,000 New Financing 06/23/10 San Diego
Startups Just Want to Have Funds: A Roundup of Recent San Diego Deals 07/24/09 San Diego
New England Venture Activity Rebounds Slightly in Q2—Region’s Top 10 Deals List 07/21/09 Boston
Aileron Therapeutics, Inc Garners $40,000,000 Series D Round 06/08/09 Boston
Having Scoured the Ocean for Cancer Drugs, Nereus Aims to Prove Its Concept Works 02/26/09 San Diego
Alios BioPharma Garners $8,400,000 Series A Financing 02/09/09 San Francisco
Ambrx Garners $28,364,000 New Round 06/30/06 San Diego
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.